Skip to main content

Prime Medicine, Inc 10-Q for FY2025 Q3

Prime Medicine, Inc. (PRME)

10-Q 2025-11-07 For: 2025-09-30
View Original
Added on April 07, 2026

About this 10-Q

Prime Medicine, Inc filed this 10-Q on November 7, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.23M
up 486.1% from $209K a year earlier
Net loss
$50.58M
compared with a net loss of $52.52M a year earlier
Diluted EPS
-$0.32
compared with -$0.44 a year earlier